CDH1 and neoplasm: Genetic inactivation of AXL in mesenchymal tumor cells leads to a decrease in the expression of mesenchymal markers, an increase in the expression of the epithelial marker E-cadherin, and reduced invasive potential [15,34,41,42,62].